[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100605156":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":21,"centralContacts":25,"locations":31,"responsibleParty":46,"collaborators":20,"id":48,"slug":20,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":51,"acronym":20,"eligibilityCriteria":52,"healthyVolunteers":49,"sex":53,"minAge":54,"maxAge":20,"enrollmentInfo":55,"targetDuration":20,"studyType":58,"phases":59,"briefSummary":61,"conditions":62,"keywords":20,"overallStatus":33,"whyStopped":20,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"University of Minnesota","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"tDCS","EXPERIMENTAL","All intervention sessions will use the Soterix Mini-CT Remote tDCS device",[13],"Device: Transcranial Direct Current Stimulation (tDCS)",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Transcranial Direct Current Stimulation (tDCS)","We will deliver 2-mA tDCS current intensity during a 30 minute stimulation period (including a 30-second ramp-up and 30-second ramp-down period) to the dorsolateral prefrontal cortex. Electrodes will be fixed on marked locations based on the 10-20 EEG system. Anodal stimulating electrode will be over the left DLPFC (F3) and cathodal electrode over the right DLPFC (F4).",[9],null,[22],{"name":23,"affiliation":5,"role":24},"Jazmin Camchong, PhD","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},"Calvin Cahill","CONTACT","952-444-0137","cahil138@umn.edu",[32],{"facility":5,"status":33,"city":34,"state":35,"zip":36,"country":37,"cosmosGeoPoint":38,"geoPoint":43,"contacts":44},"RECRUITING","Minneapolis","Minnesota","55455","United States",{"type":39,"coordinates":40},"Point",[41,42],-93.26384,44.97997,{"lat":42,"lon":41},[45],{"name":27,"role":28,"phone":29,"phoneExt":20,"email":30},{"type":47,"investigatorFullName":20,"investigatorTitle":20,"investigatorAffiliation":20,"oldNameTitle":20,"oldOrganization":20},"SPONSOR","100605156",false,"NCT07158853","Combined tDCS and Cognitive Training as an Adjunctive Treatment in Opioid Use Disorder","Inclusion Criteria:\n\n* Ability to provide consent and comply with study procedures\n* Diagnostic and Statistical Manual of Mental Disorders criteria for OUD\n* Undergoing medication treatment for OUD. Participants may have current comorbid drug use, but primary diagnosis must be OUD\n* Intention to remain in the study until intervention completion.\n\nExclusion Criteria:\n\n* Any medical condition with neurological sequelae\n* Head injury resulting in skull fracture or loss of consciousness of \\>30 minutes\n* Any tDCS or MRI contraindication (tDCS: history of seizures, metallic cranial plates\u002Fscrews or implanted device, history of eczema on scalp. MRI: unapproved metallic implants, pacemakers or any other implanted electrical device, shrapnel, metallic braces, non-removable body piercings, pregnancy, breathing or movement disorder, or claustrophobia)\n* Any psychotic disorder (participants with other treated and stable psychiatric disorders will be included)\n* Presence of a condition that would render study measures impossible to administer or interpret\n* Age younger than 18\n* Primary current substance use disorder on a substance other than opioids except for caffeine or nicotine\n* In treatment instead of jail\n* Pregnancy\n* Disrespectful behavior towards the investigators and staff.","ALL","18 Years",{"count":56,"type":57},40,"ESTIMATED","INTERVENTIONAL",[60],"PHASE1","The overall goal of this study is to investigate the added benefit of a neuromodulation intervention in individuals taking medication for treatment for Opioid Use Disorder(OUD).",[63],"Opioid Use Disorder","2026-06-26",{"date":66,"type":67},"2026-06-30","ACTUAL",{"date":69,"type":67},"2026-02-04",{"date":71,"type":57},"2027-08-31",{"name":5,"class":6},1]